Clinical Trial Update: Open Label Trial of NanoDOX Hydrogel in Orthopedic Trauma Wounds With and Without Vacuum Assisted Closure Therapy [Phase 2]

View source ↗

Summary

Phase 2 open-label trial of NanoDOX Hydrogel for orthopedic trauma wounds, with and without vacuum-assisted closure therapy, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Orthopedic Trauma Wounds

Drugs mentioned

• NanoDOX Hydrogel (NanoDOX hydrogel)

Snippet

Sponsor: NanoSHIFT LLC | Conditions: Orthopedic Trauma Wounds | Phase 2 | Status: WITHDRAWN